Ethics of the early intervention in the treatment of schizophrenia

Psychiatria Danubina

Volumn 19, Issue 3, 2007, Pages 209-215

  Filaković, Pavo ^a   Degmečic, Dunja ^a   Koić, Elvira ^b   Benić, Domagoj ^a  

^a UNIVERSITY HOSPITAL OSIJEK   (Croatia)

^b General Hospital Virovitica   (Croatia)

Author keywords

Early interventions; Ethics; Prodrome; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

CARDIOVASCULAR DISEASE; CHILD PSYCHIATRY; CONFERENCE PAPER; CONFIDENTIALITY; DRUG EFFICACY; EARLY INTERVENTION; EXTRAPYRAMIDAL SYMPTOM; HUMAN; INFORMED CONSENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MENTAL HEALTH; METABOLIC DISORDER; PATIENT AUTONOMY; PATIENT INFORMATION; PATIENT RIGHT; PREDICTION; PRESCRIPTION; PSYCHOPHARMACOLOGY; PSYCHOSIS; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CONFIDENTIALITY; EARLY DIAGNOSIS; ETHICS, MEDICAL; HUMANS; INFORMED CONSENT; LONG-TERM CARE; PREJUDICE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER; TREATMENT OUTCOME;

EID: 34948824941     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Addington J, Van Mastright S, Addington D. Duration of untreated psychosis: impact on 2-year outcome. Psychol Med 2004; 34(2):277-284.
2. Barbui C, Ciuna A, Nose M, et al. Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice. Acta Psychiatr Scand 2004; 109(4):275-278.
3. Bramble D. Annotation: the use of psychotropic medication in children: a British view. J Child Psychol Psychiatry 2003; 44(2):169-179.
4. Corcoran C, Malaspina D, Hercer L. prodromal interventions for schizophrenia vulnerability: the risk of being "at risk". Schizophrenia Research 2005;73:173-184.
5. Cornblatt BA, Lencz T, Kane JM. Treatment of the schizophrenia prodrome: is it presently ethical? Schizophrenia Research 2001; 51:31-38.
6. Correl CU, Parikh UH, Kane JM, Malhotra A. Changes in body composition in children and adolescents treated with second generation antipsychotics. Biol Psychiatry 2004;55:147S.
7. DeGrazia D. Ethical issues in early-intervention clinical trials involving minors ar risk for schizophrenia. Schizophr Res 2001; 51:77-86.
8. Glazer WM. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry 2000;61(suppl. 3):16-21.
9. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006;32:16-178.
10. Kadenhead KS. Vulnerability markers in the schizophrenia specrum:implications for phenomenology, genetics and the identification of the schizophrenia prodrome. Psychiatr Clin North Am 2002; 25(4):837-853.
11. Kogut SJ, Yam F, Dufresne F. Prescribing of antipsychotic medication in a Medicaid population: use of polytherapy and of-label dosages. J Manag Care Pharm 2005;11(1):17-24.
12. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999; 46(6):729-739.
13. Lyons JS, MacIntyre JC, Lee ME, Carpinello S, Zuber MP, Fazio ML. Psychotropic medication prescribing patterns for children and adolescents in New Yorks public mental health system. Community Ment Health J 2004; 40(2):101-118.
14. Maier W, Cornblatt BA, Merikangas KR. Transition to schizophrenia and related disorders: toward to taxonomy of risk. Schizophr Bull 2003;29(4):693-701.
15. McGashan TH. Treating schizophrenia earlier in life and the potential for prevention. Curr Psychiatry Rep 2000;2:386-392.
16. McGlashan TH, Hofman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637-648.
17. McGlashan TH. Psychosis treatment prior to psychosis onset: ethical isues. Schizoprenia Research 2001;51:47-54.
18. McGorry PD, Yung A, Philips L. Ethic and early intervention in psychosis: keeping up the pace and staying in step. Schizophrenia Research 2001;51:17-29.
19. Miller VA, Drotar D, Kodish E. Children's competence for assent and consent: a review of empirical findings. Ethics Behav 2004; 14(3):255-295.
20. Schaffner KF, McGorry PD. Preventing severe mental ilnesses - new prospects and ethical challenges. Schizophrenia Research 2001; 51:3-15.
21. Yung A. Two-year follow up of UHR individuals at the PACE clinic. Schizophr Res 2004;70(suppl.1):43.
22. Yung AR, McGorry PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353-370.